Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Ocrevus (ocrelizumab) for the Treatment of Multiple Sclerosis

Drug (Brand / Generic)

Ocrevus (ocrelizumab)

Product Description

Humanised monoclonal antibody

Current Indication

Multiple sclerosis

Market Sector

CNS

Developer

Genentech

Development Status

Under review in the US and Europe
Expand

Go Top